June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Upregulated YAP activity and histone acetylation modulate glaucomatous trabecular meshwork cell dysfunction
Author Affiliations & Notes
  • Haiyan Li
    Ophthalmology & Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States
  • Daniel W Stamer
    Department of Ophthalmology, Duke University, Durham, North Carolina, United States
  • Preethi S Ganapathy
    Ophthalmology & Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States
  • Samuel Herberg
    Ophthalmology & Visual Sciences, SUNY Upstate Medical University, Syracuse, New York, United States
  • Footnotes
    Commercial Relationships   Haiyan Li None; Daniel Stamer None; Preethi Ganapathy None; Samuel Herberg None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 809. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Haiyan Li, Daniel W Stamer, Preethi S Ganapathy, Samuel Herberg; Upregulated YAP activity and histone acetylation modulate glaucomatous trabecular meshwork cell dysfunction. Invest. Ophthalmol. Vis. Sci. 2022;63(7):809.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The extracellular matrix (ECM) in the glaucomatous trabecular meshwork (GTM) is markedly stiffened. This potent biophysical cue drives progressive cellular dysfunction. Increased Yes-associated protein (YAP) activity is linked to GTM cell pathobiology, and a recent genome-wide study identified YAP1 among novel glaucoma risk loci. Epigenetic modifications such as histone acetylation are further associated with TM failure in glaucoma. Yet, the molecular underpinnings of cellular dysfunction in response to TM stiffening, and the contributions of YAP signaling and epigenetic remodeling remain unclear. Here, we investigate the effects of ECM stiffness modulation on YAP activity and histone acetylation, and how these elements modulate GTM cell dysfunction using ECM hydrogels.

Methods : ECM hydrogels were made by photocrosslinking functionalized collagen type I, elastin-like polypeptide, and hyaluronic acid. Bioinert alginate was incorporated to facilitate stiffening (via Ca2+ crosslinking) and dynamic softening (via alginate lyase degradation) of ECM-alginate hydrogels. Donor-derived normal TM (NTM)/GTM cells were plated on/encapsulated in hydrogels and stimulated with histone deacetylase inhibitor trichostatin-A (TSA; 150 nM) or histone acetyltransferase inhibitor garcinol (5 µM). Fibrotic marker level expression, YAP activity, cytoskeletal/nuclear organization, and histone acetylation were quantified.

Results : ECM-alginate hydrogel stiffness was increased ~3-fold upon Ca2+ crosslinking (p<0.001); alginate lyase treatment restored soft baseline levels. ECM stiffening increased F-actin, alpha-smooth muscle actin, nuclear size/tension, YAP nuclear localization, and histone acetylation in NTM and GTM cells (p<0.05). These pathological features were completely reversed in NTM cells by ECM softening, while GTM cells displayed a persistent fibrotic phenotype with elevated histone acetylation. Strikingly, NTM cells in a soft ECM environment treated with TSA showed increased YAP transcriptional activity, nuclear size/tension, and F-actin compared to controls (p<0.001). Likewise, GTM cells treated with garcinol exhibited markedly decreased nuclear YAP and expression of fibrotic markers.

Conclusions : Our data suggest that targeting ECM stiffening to interrupt aberrant YAP signaling and histone acetylation is emerging as a promising strategy to permanently restore TM tissue function in glaucoma.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×